Variability in tacrolimus blood levels increases the risk of late rejection and graft loss after solid organ transplantation in older children

Pediatric Transplantation

Volumn 14, Issue 8, 2010, Pages 968-975

  Pollock Barziv, Stacey M ^a   Finkelstein, Yaron ^a,b   Manlhiot, Cedric ^a   Dipchand, Anne I ^a   Hebert, Diane ^a   Ng, Vicky L ^a   Solomon, Melinda ^a   McCrindle, Brian W ^a   Grant, David ^a  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

late allograft rejection; medication non adherence; pediatric solid organ transplantation; tacrolimus levels

Indexed keywords

AZATHIOPRINE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; STEROID; TACROLIMUS;

ADULT; ARTICLE; CARDIAC GRAFT REJECTION; CHILD; CLINICAL ASSESSMENT; DISEASE ASSOCIATION; DRUG BLOOD LEVEL; FEMALE; GRAFT FAILURE; GRAFT REJECTION; GRAFT SURVIVAL; HEART TRANSPLANTATION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; LATE GRAFT REJECTION; LIVER GRAFT REJECTION; LIVER TRANSPLANTATION; LUNG GRAFT REJECTION; LUNG TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; ORGAN TRANSPLANTATION; REPRODUCIBILITY; RISK FACTOR; SCHOOL CHILD;

ADOLESCENT; ALGORITHMS; CHILD; CHILD, PRESCHOOL; CYCLOSPORINE; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; LIVER TRANSPLANTATION; LOGISTIC MODELS; MALE; PATIENT COMPLIANCE; RETROSPECTIVE STUDIES; RISK FACTORS; TACROLIMUS;

EID: 78649900565     PISSN: 13973142     EISSN: 13993046     Source Type: Journal    
DOI: 10.1111/j.1399-3046.2010.01409.x     Document Type: Article

References (38)

1. Webber SA, Naftel DC, Parker J, et al. Late rejection episodes more than one year after pediatric heart transplant: Risk factors and outcomes. J Heart Lung Transplant 2003: 22: 869-875.
2. Benfield MR, McDonald RA, Bartosh S, Ho PL, Harmon W,. Changing Trends in pediatric transplantation; 2001 Annual report of the North American Pediatric Renal Transplant Cooperative Study. Pediatr Transplant 2003: 7: 321-335.
3. D'antiga L, Dhawan A, Portmann B, et al. Late cellular rejection in pediatric liver transplantation: Aetiology and outcome. Transplantation 2002: 73: 80-84.
4. Soltys KA, Mazariegos GV, Squires RH, Sindhi RK, Anand R,; SPLIT R esearch G roup. Late graft loss or death in pediatric liver transplantation: An analysis of the SPLIT database. Am J Transplant 2007: 7: 2165-2171.
5. Venkat VL, Nick TG, Wang Y, Bucavalas JC,. An objective measure to identify pediatric liver transplant recipients at risk for late allograft rejection related to nonadherence. Pediatr Transplant 2008: 12: 67-72.
6. Shemesh E, Annuziato RA, Schneider BL, et al. Improving adherence to medications in pediatric liver transplant recipients. Pediatr Transplant 2008: 12: 316-323.
7. Shemesh E, Schneider BL, Savitsky JK, et al. Medication adherence in pediatric and adolescent liver transplant recipients. Pediatrics 2004: 113: 825-832.
8. Stuber ML, Shemesh E, Seacord D, Washington J, Hellermann G, McDiarmid S,. Evaluating nonadherence to immunosuppressant medications in pediatric liver transplant recipients. Pediatr Transplant 2008: 12: 284-288.
9. Fine RN, Becker Y, Degeest S, et al. Nonadherence consensus conference summary report. Am J Transplant 2009: 9: 35-41.
10. George J, Phun Y-T, Bailey MJ, Kong D, Stewart K,. Development and validation of the medication regimen complexity index. Ann Pharmacother 2004: 38: 1369-1376.
11. Griffin KJ, Elkin TD,. Non-adherence in pediatric transplantation: A review of the existing literature. Pediatr Transplant 2001: 5: 246-249.
12. Stewart S, Winters GL, Fishbein MC, et al. Revision of the 1990 formulation for the standardization of nomenclature in the diagnosis of heart rejection. J Heart Lung Transplant 2005: 24: 1710-1720.
13. Stewart S, Fishbein MC, Snell GI, et al. Revision of the 1996 Working Formulation for the Standardization of Nomenclature in the Diagnosis of Lung Rejection. J Heart Lung Transplant 2007: 23: 1229-1242.
14. Solez K, Colvin RB, Racusen LC, et al. Banff 07 classification of renal allograft pathology: Updates and future directions. Am J Transplant 2008: 8: 753-760.
15. Soltys KA, Mazariegos GV, Squires RH, Sindhi RK, Anand R,; SPLIT R esearch G roup. Banff schema for grading liver allograft rejection: An international consensus document. Am J Transplant 2007: 7: 2165-2171.
16. Boucek MM, Aurora P, Edwards LB, et al. Registry of the International Society for Heart and Lung Transplantation: Tenth official pediatric heart transplantation report-2007. J Heart Lung Transplant 2007: 26: 796-807.
17. Bartosh SM, Leverson G, Robillard D, et al. Long-term outcomes in pediatric renal transplant recipients who survive into adulthood. Transplantation 2003: 76: 1195-1200.
18. Busuttil RW, Farmer DG, Yersiz H, et al. Analysis of long-term outcomes of 3200 liver transplantations over two decades: A single-center experience. Ann Surg 2005: 241: 905-918.
19. Shemesh E, Schneider BL, Emre S,. Adherence to medical recommendations in pediatric transplant recipients: Time for action. Pediatr Transplant 2008: 12: 281-283.
20. Matsui D,. Current issues in pediatric medication adherence. Paediatr Drugs 2007: 9: 283-288.
21. Dunbar-Jacob Erlen JA, Schlenk EA, Ryan CM, Sereika SM, Doswell WM,. Adherence in chronic disease. Annu Rev Nurs Res 2000: 18: 48-90.
22. Schafer-Keller P, Steiger J, Bock A, Denhaerynck K, Degeest S,. Diagnostic accuracy of measurement methods to assess non-adherence to immunosuppressive drugs in kidney transplant recipients. Am J Transplant 2008: 8: 616-626.
23. Chisholm-Burns MA, Spivey CA, Rehfeld R, Zawaideh M, Roe DJ, Gruessner R,. Immunosuppressant therapy adherence and graft failure among pediatric renal transplant recipients. Am J Transplant 2009: 9: 2497-2504.
24. Pinsky BW, Takemoto SK, Lentine KL, Burroughs TE, Schnitzler MA, Salvalaggio PR,. Transplant outcomes and economic costs associated with patient noncompliance to immunosuppression. Am J Transplant 2009: 9: 2597-2606.
25. Ringewald JM, Gidding SS, Crawford SE, Backer CL, Mavroudis C, Pahl E,. Non-adherence is associated with late rejection in pediatric heart transplant recipients. J Pediatr 2001: 139: 75-78.
26. Dew MA, Kormos RL, Roth LH,. Early post-transplant medical compliance and mental health predict physical morbidity and mortality one to three years after heart transplantation. J Heart Lung Transplant 1999: 18: 549-562.
27. Rodrigue JR, Macnaughten K, Hoffman RG, et al. Transplantation in children: A longitudinal assessment of mothers' stress, coping, and perceptions of family functioning. Psychosomatics 1997: 38: 478-486.
28. Dobbels F, Van Damme-Lombaert R, Vanhaecke J, De Geest S,. Growing pains: Non-adherence with immunosuppressive regimen in adolescent transplant recipients. Pediatr Transplant 2005: 9: 381-390.
29. Denhaerynck K, Dobbels F, Cleemput I, et al. Prevalence, consequences, and determinants of non-adherence in adult renal transplant patients: A literature review. Transpl Int 2005: 18: 1121-1133.
30. Cupples S, Dew MA, Grady KL, et al. Report of the Psychosocial Outcomes Work Group of the Nursing and Social Sciences Council of the International Society for Heart & Lung Transplant: Present status of research on psychosocial outcomes in cardiothoracic transplantation: Review and recommendations for the field. J Heart Lung Transplant 2006: 25: 716-725.
31. Gaston RS,. Noncompliance in solid organ transplantation. Curr Opin Organ Transplant 2001: 6: 164.
32. Dew MA, Dimartini AF, De Vito Dabbs A, et al. Rates and risk factors for non-adherence to the medical regimen after adult solid organ transplantation. Transplantation 2007: 83: 858-873.
33. Hansen R, Seifeldin R, Noe L,. Medication adherence in chronic disease/l Issues in post transplant immunosuppression. Transplant Proc 2007: 39: 1287-1300.
34. Burkart GL, Liu XI,. Pharmacogenetics in transplant patients. Can it predict pharmacokinetics and pharmacodynamics. Ther Drug Monit 2006: 28: 23-30.
35. Coto E, Tavira B,. Pharmacogenetics of calcineurin inhibitors in renal transplantation. Transplantation 2009: 88: S62-S67.
36. Staatz CE, Tett SE,. Clinical pharmacokinetics and pharmacodynamics of tacrolimus in solid organ transplantation. Clin Pharmacokinet 2004: 43: 623-653.
37. Van Gelder T,. Drug interactions with tacrolimus. Drug Saf 2002: 25: 707-712.
38. Bucuvalas JC, Ryckman FC, Arya G, et al. A novel approach to managing variation: Outpatient therapeutic monitoring of calcineurin inhibitor blood levels in liver transplant recipients. J Pediatr 2005: 146: 744-750.